全球靜脈注射沖洗注射器市場 - 2025 - 2033

2024年，全球靜脈沖洗注射器市場規模達4.9億美元，預計到2033年將達到8.0億美元，2025-2033年預測期間複合年成長率為5.7%。

IV 沖洗注射器是一種醫療設備，主要用於沖洗靜脈 (IV) 管線，使其保持透明（開放）且無阻塞。沖洗液通常由無菌鹽水溶液組成，通常為 0.9% 氯化鈉，與體液相容。這個過程在許多醫療環境中至關重要，特別是對於透過靜脈注射治療接受藥物的患者。提供藥物後，生理食鹽水沖洗有助於將剩餘的藥物透過靜脈輸液管推入患者的血液中，確保充分給藥。當透過同一條管線供應多種藥物時，劑量之間的沖洗有助於消除不相容藥物之間潛在的相互作用。

靜脈注射器的需求不斷成長是預測期內推動市場的促進因素。慢性病盛行率的上升增加了靜脈注射程序和治療的數量，從而增加了對靜脈注射器的需求。例如，根據國際糖尿病聯盟的預測，到 2045 年，IDF 預測顯示，每 8 名成年人中就有 1 人（約 7.83 億人）患有糖尿病，這一數字增加了 46%。超過 90% 的糖尿病患者患有第 2 型糖尿病，這是由社會經濟、人口、環境和遺傳因素所驅動的。

市場動態：

驅動程式和限制

靜脈注射器的需求不斷增加

對靜脈注射器的需求不斷成長預計將成為全球靜脈注射器市場成長的重要因素。糖尿病、心血管疾病和癌症等慢性疾病的盛行率不斷上升，技術進步以及最近的產品發布和批准增加了對靜脈注射器的需求並推動了市場的發展。

慢性病發病率的上升預計將顯著擴大市場。糖尿病、心血管疾病、癌症、慢性阻塞性肺病 (COPD)、關節炎、骨質疏鬆症在全球呈上升趨勢，導致就診次數增多，患者住院時間延長。根據醫療保健資料，每年有數百萬患者被診斷出患有這些疾病，需要擴大醫療護理，其中通常包括靜脈注射藥物。因此，醫療機構對靜脈注射器的需求不斷增加，這對於維持靜脈輸液管的完整性和確保正確的藥物輸送至關重要。

例如，根據美國疾病管制與預防中心的數據，大約 2,010 萬名 20 歲及以上的成年人患有冠狀動脈疾病，這一比例在美國約為 7.2%。根據國家生物技術資訊中心的數據，2023 年，骨質疏鬆症是全球和熱帶國家最常見的代謝性骨病。停經後女性骨質疏鬆症盛行率為30%至50%，50歲以上男性骨質疏鬆症盛行率高達20%。此外，據世界衛生組織稱，到2023 年，癌症、慢性阻塞性肺病、哮喘、糖尿病和心血管疾病等疾病影響低收入和中等收入國家的人們，這些國家的非傳染性疾病死亡人數佔全球非傳染性疾病死亡人數的四分之三以上（31.4百萬）的發生率高達 80% 左右。大約 1700 萬人在 70 歲之前死於非傳染性疾病。

此外，醫療保健基礎設施和技術的不斷改進正在推動市場成長。醫院和醫療機構擴大使用優先考慮病人安全和用藥準確性的標準程序。預充鹽水靜脈注射器可降低感染風險並確保劑量準確，在醫療保健提供者中越來越受歡迎。在旨在提高病患安全和減少藥品缺陷的嚴格限制的背景下，這種趨勢尤其重要。因此，製造商正在投資研發，以徹底改造其產品，並滿足醫療保健從業者和患者不斷變化的需求。

例如，2023 年 5 月，老牌醫療技術公司 BD 向客戶提供了一款帶有整合式消毒裝置的一體式預充式沖洗注射器，旨在提高感染預防合規性並簡化醫生工作流程。 BD PosiFlush SafeScrub 是一款預裝鹽水沖洗注射器，其特點是在注射器的尖端蓋中內置有主動消毒裝置，體外測試證明該裝置可顯著減少與 CRBSI 相關的微生物生長。

與靜脈注射器相關的併發症

與靜脈注射器相關的併發症等因素預計將阻礙全球靜脈注射器市場。當一個或多個氣泡進入動脈或靜脈並限制血流時，就會形成空氣栓塞。注射器或靜脈注射可能會無意中將空氣注入靜脈。大多數空氣栓塞是良性的，會產生非常微妙的症狀，或者根本不會產生症狀。這些通常會自行消失，不會產生任何負面影響。

然而，空氣栓塞極為罕見，很少影響腦部、心臟或肺部。如果這樣做，可能會導致心臟病發作、中風或呼吸衰竭。此外，液體超負荷和過敏反應是氯化鈉沖洗的兩個更嚴重的副作用。儘管相對不常見，但這兩種情況都可能致命，並會增加沖洗注射器的召回率。因此，從上述陳述來看，預計市場在預測期內將受到阻礙。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動力學

• 影響因素
  • 促進要素
  • 靜脈沖洗注射器的需求不斷增加
  • 限制
  • 與靜脈注射注射器相關的併發症
  • 機會
  • 影響分析

第 5 章：產業分析

• 波特五力分析
• 供應鏈分析
• 定價分析
• 監管分析
• 報銷分析
• 專利分析
• SWOT分析
• DMI 意見

第 6 章：依產品

• 鹽水沖洗注射器
• 肝素沖洗注射器

第 7 章：按技術

• 手動的
• 自動化

第 8 章：依材料類型

• 塑膠
• 玻璃

第 9 章：最終用戶

• 醫院
• 診所
• 家庭護理設置

第 10 章：按地區

• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 歐洲其他地區
• 南美洲
  • 巴西
  • 阿根廷
  • 南美洲其他地區
• 亞太
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 中東和非洲

第 11 章：競爭格局

• 競爭場景
• 市場定位/佔有率分析
• 併購分析

第 12 章：公司簡介

• BD
• 公司概況
• 產品組合和描述
• 財務概覽
• 主要進展
• Medline Industries, LP
• ICU Medical, Inc.
• Terumo Corporation
• SPM Medicare
• Nipro Medical Corporation
• B. Braun SE
• Cardinal Health
• Vygon
• Teleflex Incorporated

第 13 章：附錄

The global IV flush syringe market reached US$ 0.49 billion in 2024 and is expected to reach US$ 0.80 billion by 2033, growing at a CAGR of 5.7% during the forecast period 2025-2033.

An IV flush syringe is a medical device used primarily for flushing intravenous (IV) lines, keeping them transparent (open) and free of blockages. The flush is normally made up of a sterile saline solution, usually 0.9% sodium chloride, that is compatible with the body's fluids. This process is critical in many medical settings, especially for patients receiving drugs via IV treatment. After providing drugs, a saline flush helps push any remaining drug through the IV line into the patient's bloodstream, ensuring full medication administration. When numerous medications are supplied through the same line, flushing between doses helps eliminate potential interactions between incompatible drugs.

The increasing demand for IV flush syringes is the driving factor that drives the market over the forecast period. The rising prevalence of chronic diseases increases the number of intravenous procedures and treatments which increases the demand for the IV flush syringe. For instance, according to the International Diabetes Federation, By 2045, IDF projections show that 1 in 8 adults, approximately 783 million, will be living with diabetes, an increase of 46%. Over 90% of people with diabetes have type 2 diabetes, which is driven by socio-economic, demographic, environmental, and genetic factors.

Market Dynamics: Drivers & Restraints

Increasing demand for IV flush syringes

Increasing demand for IV flush syringes is expected to be a significant factor in the growth of the global IV flush syringe market. The rising prevalence of chronic diseases, such as diabetes, cardiovascular conditions, and cancer, technological advancements, and recent product launches and approvals increase the demand for the IV flush syringe and drive the market.

The rising frequency of chronic diseases is predicted to significantly expand the market. Diabetes, cardiovascular diseases, cancer, chronic obstructive pulmonary disease (COPD), and arthritis, osteoporosis are all on the rise across the globe, resulting in more hospital visits and longer patient stays. According to healthcare data, millions of patients are diagnosed with these disorders each year, necessitating extending medical care, which frequently includes intravenous medicines. As a result, healthcare facilities are experiencing an increase in demand for IV flush syringes, which are critical for preserving the integrity of IV lines and ensuring proper medication delivery.

For instance, according to the Centers for Disease Control and Prevention, around 20.1 Million adults aged 20 and older have coronary artery disease, about 7.2% in the United States. According to the National Center for Biotechnology Information, 2023, Osteoporosis is the most common metabolic bone disorder globally and in tropical countries. The prevalence of osteoporosis is 30 to 50% among postmenopausal women and up to 20% in men above 50 years. Furthermore, according to the World Health Organization, 2023, diseases like cancers, chronic obstructive pulmonary diseases, asthma, diabetes, and cardiovascular diseases affect people in low- and middle-income countries, where more than three-quarters of global NCD deaths (31.4 million) occur around up to 80%. Approximately 17 million people die from an NCD before age 70. The increasing prevalence of chronic diseases increases the demand for IV flush syringes and drives the market.

Furthermore, continual improvements in healthcare infrastructure and technology are driving market growth. Hospitals and healthcare facilities are increasingly using standard procedures that prioritize patient safety and medication accuracy. Prefilled saline IV flush syringes, which reduce the danger of infection and ensure accurate dosing, are gaining popularity among healthcare providers. This tendency is especially important in the context of strict restrictions aimed at improving patient safety and lowering pharmaceutical faults. As a result, manufacturers are investing in R&D to reinvent their product offerings and meet the changing needs of healthcare practitioners and patients alike.

For instance, in May 2023, BD, an established medical technology firm, expanded customer availability of an all-in-one prefilled flush syringe with an integrated disinfection unit, which is meant to improve infection prevention compliance and streamline physician workflow. BD PosiFlush SafeScrub is a prefilled saline flush syringe that features an active disinfection unit built right into the tip cap of the syringe that is demonstrated via in vitro testing to significantly reduce microbial growth associated with CRBSIs.

Complications associated with IV flush syringes

Factors such as complications associated with IV flush syringes are expected to hamper the global IV flush syringe market. An air embolism develops when one or more air bubbles enter an artery or vein and restrict blood flow. A syringe or IV can inadvertently inject air into a vein. The majority of air embolisms are benign, producing very subtle symptoms or none at all. These typically go away on their own without having any negative effects.

However, air embolisms are extremely rare and rarely affect the brain, heart, or lungs. If they do, a heart attack, stroke, or respiratory failure could result. Moreover, fluid overload and an allergic reaction are two more severe side effects of a sodium chloride flush. Despite being relatively uncommon, both can be fatal and increase recalls of flush syringes. Thus, from the above statements, the market is expected to be hampered in the forecast period.

Segment Analysis

The global IV flush syringe market is segmented based on offerings, application, type, end-user, and region.

Saline flush syringes segment is expected to dominate the global IV flush syringe market share

One of the primary drivers of this trend is an increasing awareness of the need to preserve IV-line patency in clinical settings. Saline flush syringes, particularly prefilled ones, offer healthcare providers a convenient and efficient way to drain intravenous lines, ensuring that medications are given effectively and without interruption. This is critical in managing patients with chronic disorders, who frequently require continual intravenous therapy. As hospitals and clinics aim to improve patient safety and streamline processes, the use of saline flush syringes is projected to increase significantly.

The segment benefits because the hazards of microbial contamination that arise when doses are drawn up at the ward level are eliminated by the use of prefilled saline syringes. Additionally, the chance of incorrect selection is decreased by the completely labeled nature of prefilled syringes. The time saved by nurses is another important issue. Ad hoc preparation of intravenous dosages incurs costs (including disposables and nurse time) that are frequently disregarded but can pile up in a busy ward. According to one study, using prefilled syringes reduced nursing time by 42% compared to using traditional injection systems.

Furthermore, developments in medical technology and product design enable saline flush syringes to maintain their market dominance. Manufacturers are concentrating on creating novel prefilled saline syringes that shorten the preparation time and limit the danger of contamination. These solutions not only improve healthcare staff workflow efficiency but also increase patient safety by lowering the risk of needlestick injuries and infections. For instance, in September 2023, AMSINO launched the Prefilled Normal Saline Flush Syringe. This product is intended to improve the safety and efficiency of intravenous therapy by offering a prefilled saline solution that reduces the risk of contamination and makes the flushing procedure easier for healthcare practitioners. The syringes are DEHP-free, PVC-free, and latex-free, fulfilling contemporary requirements for patient safety and comfort.

Geographical Analysis

North America is expected to hold a significant position in the global IV flush syringe market share

The dominance of the North American market in the global IV flush syringe market is driven by several key factors such as the high concentration of hospitals, clinics, and specialized medical facilities, and the increasing prevalence of chronic diseases.

The rising incidence of chronic diseases in North America is driving up demand for IV flush syringes. Diabetes, cardiovascular disease, and cancer are becoming more prevalent, resulting in increasing hospitalization rates and a growing demand for effective medication administration systems. According to American Hospital Association data, hospital admissions in the United States have been constantly increasing, with millions of patients requiring intravenous therapies that use flush syringes.

For instance, according to the National Institute of Health, in 2023, the United States is expected to see 1,958,310 new cancer cases and 609,820 cancer deaths. Prostate cancer incidence climbed by 3% every year from 2014 to 2019, after two decades of reduction, resulting in an additional 99,000 new cases. The annual cancer incidence rate is 440.5 per 100,000 men and women (based on cases from 2017 to 2021). The cancer death rate (cancer mortality) is 146.0 per 100,000 men and women annually. In 2024, a projected 14,910 children and adolescents between the ages of 0 and 19 will be diagnosed with cancer, with 1,590 deaths from the condition. The rising incidence of chronic diseases increases the number of intravenous treatments which increases the demand for IV flush syringes and drives the market.

Asia Pacific is growing at the fastest pace in the global IV flush syringe market

The Asia Pacific region is experiencing the highest growth in the around-the-globe IV flush syringe market, owing to many important factors. The rising frequency of chronic diseases in the region is a major cause of its rapid growth. With a growing population suffering health issues such as diabetes, cardiovascular disease, and respiratory ailments, the demand for effective medical treatments, such as IV flush syringes, has increased dramatically. This trend is accelerated by the increasing number of hospital admissions and surgical procedures that require the use of IV flush syringes to maintain clear intravenous lines and ensure efficient medication delivery.

For instance, according to the National Institute of Health, the expected number of cancer cases in India for 2022 is 14,61,427 (crude rate: 100.4 per 100,000). In India, one out of every nine people is likely to develop cancer over his or her lifetime. Males and females were most likely to develop lung and breast cancer, respectively. The rising incidence of chronic diseases increases the demand for IV flush syringes and drives the market due to an increase in the intravenous market.

Competitive Landscape

The major global players in the global IV flush syringe market include BD, Medline Industries, LP, ICU Medical, Inc., Terumo Corporation, SPM Medicare, Nipro Medical Corporation, B. Braun SE, Cardinal Health, Vygon, Teleflex Incorporated among others.

Emerging Players

Aquabiliti, Polymedicure, and Medefil, Inc among others

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global IV flush syringe market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product
• 3.2. Snippet by Technology
• 3.3. Snippet by Material Type
• 3.4. Snippet by End-User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
  • 4.1.2. Increasing Demand for IV Flush Syringes
  • 4.1.3. Restraints
  • 4.1.4. Complications associated with IV Flush Syringe
  • 4.1.5. Opportunity
  • 4.1.6. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Reimbursement Analysis
• 5.6. Patent Analysis
• 5.7. SWOT Analysis
• 5.8. DMI Opinion

6. By Product

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 6.1.2. Market Attractiveness Index, By Product
• 6.2. Saline Flush Syringes*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Heparin Flush Syringes

7. By Technology

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 7.1.2. Market Attractiveness Index, By Technology
• 7.2. Manual*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Automated

8. By Material Type

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
  • 8.1.2. Market Attractiveness Index, By Material Type
• 8.2. Plastic*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Glass

9. By End-User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.1.2. Market Attractiveness Index, By End-User
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Clinics
• 9.4. Homecare Settings

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  • 10.2.8. The U.S.
  • 10.2.9. Canada
  • 10.2.10. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  • 10.3.8. Germany
  • 10.3.9. UK
  • 10.3.10. France
  • 10.3.11. Italy
  • 10.3.12. Spain
  • 10.3.13. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  • 10.4.8. Brazil
  • 10.4.9. Argentina
  • 10.4.10. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  • 10.5.8. China
  • 10.5.9. India
  • 10.5.10. Japan
  • 10.5.11. South Korea
  • 10.5.12. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
  • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. BD*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Medline Industries, LP
• 12.3. ICU Medical, Inc.
• 12.4. Terumo Corporation
• 12.5. SPM Medicare
• 12.6. Nipro Medical Corporation
• 12.7. B. Braun SE
• 12.8. Cardinal Health
• 12.9. Vygon
• 12.10. Teleflex Incorporated

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us